Company profile
Pulmonem company profile
Pulmonem focuses on biotechnology, specifically developing treatments to combat inflammation caused by COVID-19. The company is engaged in clinical trials to demonstrate the efficacy of a generic drug in arresting the development of COVID-19 related inflammation. Pulmonem collaborates with research institutions like the McGill University Health Centre to advance its clinical trials and has received approvals from regulatory bodies such as the FDA and Health Canada.
Business identity
- Website
- https://www.pulmonem.ca
- Contact email
- [email protected]
- Phone number
- +1 613 220 2016
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $1K+
- Founded
- 2020-01-01
Headquarters
- Headquarters
- Dieppe, New Brunswick, Canada
- Postal code
- E1A 7R8
- Country code
- CA
- Continent
- North America